Results 241 to 250 of about 2,336,646 (291)

L-Arginine Activates the Neuregulin-1/ErbB Receptor Signaling Pathway and Increases Utrophin mRNA Levels in C2C12 Cells. [PDF]

Biochem Res Int
Tapia G, Fuenzalida S, Rivera C, Apablaza P, Silva M, Jaimovich E, Juretić N.   +6 more
europepmc   +1 more source

Revisiting the role of ErbBs in oligodendrocyte development. [PDF]

Proc Natl Acad Sci U S A
Zhang A.
europepmc   +1 more source

Self-association of models of transmembrane domains of ErbB receptors in a lipid bilayer. [PDF]

Biophys J, 2010
Prakash A, Janosi L, Doxastakis M.
europepmc   +1 more source

Pan-ErbB inhibition impairs cognition via disrupting myelination and aerobic glycolysis in oligodendrocytes. [PDF]

Proc Natl Acad Sci U S A
Hu X, Zhu Q, Lou T, Hu Q, Li H, Xu Y, Niu X, He L, Huang H, Qiu M, Shen Y, Jia JM, Tao Y.   +12 more
europepmc   +1 more source

Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancer. [PDF]

JCI Insight
Hesterberg AB, Wong HY, Jackson J, Antunovic M, Rios BL, Watkins E, Bergman RE, Davidson BA, Ginther SE, Graves D, Nahmias EF, Googel JA, Martin LB, Sanchez V, Gonzalez-Ericsson PI, Sheng Q, Brown BP, Meiler J, Schaffer KR, Gordetsky JB, Park BH, Hurley PJ.   +21 more
europepmc   +1 more source

Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer. [PDF]

Cell Death Dis
Sampson J, Ju HM, Zhang N, Yeoh S, Choi J, Bayliss R.   +5 more
europepmc   +1 more source

Single-molecule localization microscopy as a tool to quantify di/oligomerization of receptor tyrosine kinases and G protein-coupled receptors. [PDF]

Mol Pharmacol
Sharrocks KL, Swaih AM, Hanyaloglu AC.
europepmc   +1 more source

Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma. [PDF]

Biomark Res
Saeidpour Masouleh S, Nasiri K, Ostovar Ravari A, Saligheh Rad M, Kiani K, Sharifi Sultani A, Nejati ST, Nabi Afjadi M.   +7 more
europepmc   +1 more source

Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2. [PDF]

Mol Cancer Ther
Parakh S, Huynh N, Cao DD, Rigopoulos A, Gloria B, Burvenich IJG, Murone C, Wichmann CW, Guo NY, Senko C, Parslow A, Allan L, Osellame LD, Janes PW, Scott FE, Liu Z, Gan HK, Scott AM.   +17 more
europepmc   +1 more source